Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05146622 · ClinicalTrials.gov registry record
Virtual Sun Safe Workplaces Ph I
A clinical trial, sponsored by Klein Buendel.
- Completed
- Registry status
- 104
- Enrollment target
NCT05146622: Completed study, sponsored by Klein Buendel.
NCT05146622 is a clinical trial that has completed, run by Klein Buendel. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05146622 has completed, sponsored by Klein Buendel.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
Study Summary
Americans who work outdoors are exposed to an extreme amount of solar ultraviolet radiation over a lifetime that substantially increases their risk for developing skin cancer. In Phase I, the feasibility of a virtual learning environment (VLE) for distributing our effective Sun Safe Workplaces (SSW) intervention to American employers will be established with input from senior managers and Hispanic and African American outdoor workers and development and evaluation of a prototype of the SSW Works VLE. In Phase II, the full SSW Works will be produced and tested for effectiveness at improving outdoor workers' sun protection in a randomized trial enrolling employers nationwide.
Primary Outcome
Focus Groups and Semi-structured Interviews
Interventions
- BEHAVIORAL Workplaces in the World
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2021-10-28 |
| Est. Completion | 2022-06-30 |
What the finished NCT05146622 record still lists
NCT05146622 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Workplaces in the World is the first listed.
NCT05146622 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05146622 about?
NCT05146622 is a clinical study titled "Virtual Sun Safe Workplaces Ph I". Americans who work outdoors are exposed to an extreme amount of solar ultraviolet radiation over a lifetime that substantially increases their risk for developing skin cancer. In Phase I, the feasibility of a virtual learning environment (VLE) for distributing our effective Sun Safe Workplaces (SSW)...
What is the current status of trial NCT05146622?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2021-10-28. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT05146622?
The interventions under investigation include: Workplaces in the World (BEHAVIORAL).
Who is sponsoring clinical trial NCT05146622?
This trial is sponsored by Klein Buendel, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI